Abstract:
Objective To set up the models of human esophageal cancer in nude mice and the models of different xenograft tumors in IRM-2 mice, observe the effects of chemotherapy and radiotherapy on the tumors.
Methods Twenty-four hours after setting up the models, all the mice carrying tumors including lymphoma, hepatic carcinoma H22, leukemia L1210 and sarcoma S180 were randomly divided into 3 groups: control group, radiotherapy group and cyclophosphamidum group, 10 mice per group. Mice in cyclophosphamidum group were injected cyclophosphamidum(25 mg/kg) by intraperitoneal 4 times every other day; mice in radiotherapy group were given total body irradiation at the fourth day and last for 5 days. Mice with human esophageal cancer were randomly divided into 3 groups: control group, radiotherapy group and 5-fluorouracil group, 5 mice per group. Mice in radiotherapy group were given local body irradiation at the fourth day and the eighth day. Mice in 5-fluorouracil group were injected 5-fluorouracil(25 mg/kg) by intraperitoneal 4 times every other day. All the mice were killed at the twelfth day and the rates of tumor inhibition were calculated.
Results The tumor inhibitory rates of IRM-2 mice in radiotherapy group were 34.57%(lymphoma), 32.69%(sarcoma S180), 31.31%(hepatic carcinoma H22) and 18.32%(leukemia L1210)respectively, and there were significant difference compared with control group(t=4.130, 3.222, 3.581 and 2.713, P < 0.01, < 0.01, < 0.01 and < 0.05). The tumor inhibitory rates of nude mice with human esophageal cancer in radiotherapy group was 22.99%, but there was no significant difference compared with control group(t=1.235, P > 0.05). The tumor inhibitory rates in radiotherapy group were 74.47%(lymphoma), 72.59%(sarcoma S180), 69.12%(hepatic carcinoma H22), 77.53%(leukemia L1210) and 56.32%(human esophageal cancer), and there were significant difference compared with control group(t=12.694, 12.208, 7.223, 11.964 and 5.266, all P < 0.01).
Conclusions There were inhibitory effects of chemotherapy and radiotherapy on all types of tumors. However, the efficiency depends on the mouse strains and the type of tumor.